Peer review reports
From: A real-world disproportionality analysis of Rucaparib: Post-marketing Pharmacovigilance Data
Original Submission | ||
---|---|---|
18 May 2023 | Submitted | Original manuscript |
Resubmission - Version 2 | ||
Submitted | Manuscript version 2 | |
11 Jun 2023 | Reviewed | Reviewer Report - Kittinun Leetanaporn |
13 Jun 2023 | Reviewed | Reviewer Report - Naglaa Elabd |
18 Jun 2023 | Reviewed | Reviewer Report |
30 Jun 2023 | Author responded | Author comments - Yamin Shu |
Resubmission - Version 3 | ||
30 Jun 2023 | Submitted | Manuscript version 3 |
14 Jul 2023 | Reviewed | Reviewer Report - Kittinun Leetanaporn |
19 Jul 2023 | Reviewed | Reviewer Report - Naglaa Elabd |
Resubmission - Version 4 | ||
Submitted | Manuscript version 4 | |
Publishing | ||
20 Jul 2023 | Editorially accepted | |
11 Aug 2023 | Article published | 10.1186/s12885-023-11201-w |